This HTML5 document contains 113 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57579888
rdf:type
wikibase:Item
schema:description
scientific article published on 20 March 2014 наукова стаття, опублікована в травні 2014 artículu científicu espublizáu en marzu de 2014 im März 2014 veröffentlicher wissenschaftlicher Artikel wetenschappelijk artikel article scientifique publié en 2014
p:P577
wds:Q57579888-31367641-F7A4-4AD5-A117-DC94FC084D1C
wdt:P577
2014-03-20T00:00:00Z
p:P2860
wds:Q57579888-021CD92C-25BB-4A6B-A8F0-76146C11FAD6 wds:Q57579888-07425720-FCC8-4432-A05C-0F19611EF646 wds:Q57579888-100FFBB8-9566-4A86-B0B4-74D26AA0DFC2 wds:Q57579888-3C9F0873-99DD-4D66-BFC0-1E1765CFECD2 wds:Q57579888-445D916D-164A-42AF-84E1-0A94BA4CCC16 wds:Q57579888-63FFDB6B-13D0-4861-8CFF-F677374BFD3A wds:Q57579888-64F96939-7E2E-4320-B419-86EEDBDC2AD0 wds:Q57579888-728D861D-3D90-402A-9BB9-9C99800950CB wds:Q57579888-74B1BAB3-03BB-4CCA-A6D5-19B7620E426D wds:Q57579888-8194222F-C939-4062-A42D-EB20FEEA022A wds:Q57579888-8388CCE0-6C94-450F-A767-7E979F7D32AD wds:Q57579888-8EB071CD-7421-4953-BC6B-7E83E3F12237 wds:Q57579888-996EB2D1-ECE2-47D1-B9EB-5273E1076C1C wds:Q57579888-9A62724F-DA5B-4B98-BE30-833F18CBCF69 wds:Q57579888-9BD749C5-CE9A-43E8-B828-94613478754F wds:Q57579888-C3C36380-5C40-4543-8DD1-2337463B2F12 wds:Q57579888-FF27D07D-EE1A-44DE-9313-BD4151BA4D7F
wdt:P2860
wd:Q35710898 wd:Q37032851 wd:Q52893849 wd:Q29616112 wd:Q27824847 wd:Q52074171 wd:Q43060768 wd:Q84368801 wd:Q38188183 wd:Q34496969 wd:Q57579895 wd:Q45287928 wd:Q54668846 wd:Q84247183 wd:Q43121691 wd:Q43180234 wd:Q34116744
p:P2093
wds:Q57579888-36D2219C-6C4D-4CDF-8F61-A03841BAC7CE wds:Q57579888-2DB37F12-7E48-4BCA-9BD1-B06088039B28 wds:Q57579888-2DF16761-B3A9-4FCF-AF0C-8B6AB012A50F wds:Q57579888-137ABA66-5D71-415E-8071-9B9F58180607 wds:Q57579888-DD1972AA-40F0-4D92-B685-3CED08019AFA wds:Q57579888-7F0FC85A-EE0C-4BDF-95A4-330F7BD7713C wds:Q57579888-D4CB3356-813B-4C8A-8376-4C744FBF3F8B wds:Q57579888-A5C71EEA-472D-4944-AB6A-C1868156FC61 wds:Q57579888-A2379004-908A-45C3-B6D6-6CBD6304B2A5 wds:Q57579888-A29958B7-640F-4BB0-8825-FA00427498C5 wds:Q57579888-58152A79-B475-4352-BFD1-087F775C9836 wds:Q57579888-582FD938-D2A2-4967-995D-DAAA1E16459B wds:Q57579888-53D98D88-281B-4E8A-B0F8-A8824F9D5168 wds:Q57579888-573D9DD2-647C-461C-91A4-70CF253AEC59 wds:Q57579888-6E4735F4-8844-4F14-9E39-5E1E32F8FAD1 wds:Q57579888-63D44E41-3527-43EF-98AE-6B3D9B7BDA0C
wdt:P2093
Mauro Mansutti Wolfgang Eiermann Federico Vazquez Sergei Tjulandin Domenico Magazzù Belen Ojeda Angela Moliterni Miguel Angel Climent Dominik Heinzmann Pinuccia Valagussa Jutta Steinseifer Mikhail J Byakhov Mikhail Lichinitser Alla Bozhok Milvia Zambetti Jose Baselga
rdfs:label
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
skos:prefLabel
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
schema:name
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
p:P50
wds:Q57579888-765945F8-01DE-4C65-B5F0-D08B9255EBA6 wds:Q57579888-5B6C8A2C-32E6-467D-A8C9-FB68FD216163 wds:Q57579888-E6E6C9DA-47EF-418E-9D86-E73F8C9AB701 wds:Q57579888-F136ABA7-B6F1-4CCC-905B-E857FDE34164
wdt:P50
wd:Q28500539 wd:Q57085354 wd:Q56629673 wd:Q67755317
p:P1476
wds:Q57579888-FC4A7B38-89BA-4214-8C63-DD658F7F9EE2
wdt:P1476
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
p:P304
wds:Q57579888-437036E1-668C-46AE-AC6E-3C416ACACCC5
wdt:P304
640-647
p:P31
wds:Q57579888-9BA69EC3-0874-451C-AA07-08E8EC9B6D09
wdt:P31
wd:Q13442814
p:P921
wds:Q57579888-FB87C794-9F36-4DC5-A8FD-67B42F63E0C4 wds:Q57579888-F44BBCCA-16D5-4535-A5FB-9C2C8FF3C373 wds:Q57579888-3C45B456-580E-4C10-8993-0ECF8AFD53D0
wdt:P921
wd:Q128581 wd:Q412616 wd:Q181600
p:P698
wds:Q57579888-825379CD-4DB5-41C7-B8CE-DD03C13E9382
wdtn:P698
n12:24657003
wdt:P698
24657003
p:P1433
wds:Q57579888-1D8C539E-6E6A-4EB5-ADA7-69A0DC377CAE
wdt:P1433
wd:Q13747613
p:P433
wds:Q57579888-ABB5B4AF-5519-4338-A0D2-00E271986212
p:P478
wds:Q57579888-19F2ADB0-EBE9-4D54-BF71-EBFBAC49D50B
wdt:P433
6
wdt:P478
15
p:P356
wds:Q57579888-63C5F8C1-4D70-4C1A-A239-2EF29BF00351
wdtn:P356
n10:S1470-2045(14)70080-4
wdt:P356
10.1016/S1470-2045(14)70080-4